sellWeak10b5-1 plan
Singhal Priya sold $17k of BIIB
Head of Development at BIOGEN INC.. 110 shares at an average of $157.21, traded Dec 9, 2024, filed Dec 9, 2024.
Warning score
0Value
$17k
110 shares
Holdings after
5,426
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001127602-24-028861, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 6, 2024 | MOption exercise Common Stock10b5-1 | +426 | $0.00 | $0 | 5,742 | Dec 9, 2024 |
| Dec 6, 2024 | FTax withholding Common Stock10b5-1 | -206 | $157.78 | $33k | 5,536 | Dec 9, 2024 |
| Dec 9, 2024 | SOpen-market sale Common Stock10b5-1 | -110 | $157.21 | $17k | 5,426 | Dec 9, 2024 |
| Dec 6, 2024 | MOption exercise Restricted Stock Unitderivative10b5-1 | -426 | $0.00 | $0 | 0 | Dec 9, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.